Key Regulatory Considerations for Pharmaceuticals and Medical Devices in Japan

Key Regulatory Considerations for Pharmaceuticals and Medical Devices in Japan

I. Introduction
II. Pharmaceutical Regulations in Japan
III. Advertising and Promotional Regulations
IV. Conclusion

Authors： Kochi Hashimoto
Oh-Ebashi English Newsletter 2025 Spring Issue
Publisher：Oh-Ebashi LPC & Partners
Date of publication： March 28, 2025

Other publications by Kochi Hashimoto

2025.10.21
Lexology Panoramic Next - M&A : Japan Chapter
2025.04.01
Direction of the Revision of the Pharmaceutical and Medical Device Act and Related Systems - Quality Assurance, Stable Supply, Support for Drug Discovery, Development of Pharmacy Functions, etc.
2024.10.16
Lexology Panoramic Next - M&A : Japan Chapter
2024.05.08
mondaq - ESG Comparative Guide : Japan
2024.02.02
Understanding the Basics: Q&A on the Legal Practice on ESG and Sustainability
2024.01.12
International Trends in Business and Human Rights and the Responses of Japanese Companies
2023.10.16
Getting the Deal Through - Market Intelligence M&A : Japan Chapter
2023.06.23
Business and Human Rights in Japan
2023.05.11
The Legal 500 Country Comparative Guides Japan Environmental, Social and Governance
2023.02.28
Impact of the Enactment of the German Act, "Act on Corporate Due Diligence in Supply Chains," on Japanese Companies
2020.12.01
Start-up Investment Agreement – Model Agreement and Commentary Thereon
2019.06.21
Best Practices of Forming Venture Capital Funds - A Commentary on the New Model Contract and the Market-Value Valuation Method
2018.03.19
The Problem of Unknown Land Owners and the Japanese Real Estate Registration System
2016.09.20
Web Commentary on TPP "22　Competitiveness and Business Facilitation"
2016.09.20
Web Commentary on TPP "24 Small and Medium-Sized Enterprises"
2016.08.15
Issues in TPP:Reading Its Reality and Future in the Agreement:TPP:Integrating SMEs into Global Supply Chains

MORE

Contact us

ページTOPへ